Mylan Pharma has received USFDA approval for its biologics licence application (BLA) for MYL-1401H, a proposed biosimilar Pegfilgrastim. The proposed biosimilar Pegfilgrastim is one of […]
Zydus Cadila has received final USFDA approval to market fluconazole tablets used for the treatment of fungal infections in USA market. The company also received […]
Lupin has received final approval from USFDA to market its generic version of Mylan’s triamcinolone acetonide cream used for treatment of skin disease. The approval […]
Copyright © 2026 | WordPress Theme by MH Themes